UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
____________________________________________________________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
___________________________________________________________________
Date
of
Report (Date of earliest event reported): February
8, 2008
XCORPOREAL,
INC.
(Exact
Name of Registrant as Specified in Charter)
|
Delaware
|
0-18718
|
75-2242792
|
|
(State
or other jurisdiction of
incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
11150
Santa Monica Boulevard, Suite 340, Los Angeles, California
90025
(Address
of principal executive offices) (Zip Code)
(310)
481-8986
(Registrant's
telephone number, including area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR
240.13e-4(c))
| Item 5.02 |
Departure Of Directors Or
Principal
Officers; Election Of Directors; Appointment Of Principal
Officers. |
Effective
February 8, 2008, Daniel Goldberger was appointed our Chief Executive Officer.
We entered into a Services Agreement with Mr. Goldberger which continues until
our employment of a permanent CEO, as set forth in our current report on Form
8-K filed January
25, 2008, and incorporated herein by reference. Mr. Goldberger will act as
our
CEO in the interim.
Mr.
Goldberger,
age 49,
has served as a member of our Board of Directors since October 2007, and served
as a Director, President and Chief Operating Officer of pre-merger Xcorporeal
from October 2006 to August 2007. He has served as Chief Executive Officer
of
Sound Surgical Technologies, a privately held manufacturer of equipment for
ultrasound assisted liposuction, since August 2007. Mr. Goldberger served as
Chief Executive Officer of Glucon Inc., a privately held glucose monitoring
business from 2004 to 2007. From 2001 to 2004, Mr. Goldberger served as
President and as a Director of the Medical Group of OSI Systems, Inc. (NASDAQ:
OSIS), which included the Spacelabs, Dolphin, Osteometer product lines with
combined revenue approaching $250 million. He was also the co-founder of
Optiscan Biomedical Corporation, where he served as Director from 1994 to 2001
and also served as its Vice President from 1994 to 1998 and then as its
President from 1998 to 2001. Mr. Goldberger has over 25 years of management
experience with large and small medical device companies, including Nellcor
and
Square One Technology. He received his B.S.M.E. from Massachusetts Institute
of
Technology and his M.S.M.E. from Stanford University.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
| |
XCORPOREAL,
INC. |
|
|
|
| Date: February
8,
2008 |
By: |
/s/ ROBERT
WEINSTEIN |
| |
Robert
Weinstein
Chief
Financial Officer
|
| |
|